Cardiopulmonary Bypass Duration is an Independent Predictor of Morbidity and Mortality After Cardiac Surgery
Overview
Authors
Affiliations
Objective: The aim of this study was to determine if there is a direct relationship between the duration of cardiopulmonary bypass (CPB time [CPBT]) and postoperative morbidity and mortality in patients undergoing cardiac surgery.
Design: Retrospective study.
Setting: Cardiac surgery unit, university hospital.
Participants: Five thousand six patients, New York Heart Association classes 1 through 4, who underwent cardiac surgery between January 2002 and March 2008.
Interventions: All patients were subjected to CPB.
Measurements And Main Results: The mean CPBT was 115 minutes (median 106). One hundred thirty-one patients (2.6%) died during the same hospitalization. The postoperative median blood loss was 600 mL. Reoperations for bleeding occurred in 193 patients (3.9%), and 1,001 patients received 3 or more units of red blood cells. There were 108 patients (2.2%) with neurologic sequelae, 391 patients (7.8%) with renal complications, 37 patients (0.7%) with abdominal complications, and 184 patients (3.7%) with respiratory complications. Seventy-two patients (1.4%) had an infective complication, and 80 patients (1.6%) had a postoperative multiorgan failure. The multivariate analysis confirmed the role of CPBT, considered in 30-minute increments, as an independent risk factor for postoperative death (odds ratio [OR] = 1.57, p < 0.0001), pulmonary (OR = 1.17, p < 0.0001), renal (OR 1.31, p < 0.0001), and neurologic complications (OR = 1.28, p < 0.0001), multiorgan failure (OR = 1.21, p < 0.0001), reoperation for bleeding (OR = 1.1, p = 0.0165), and multiple blood transfusions (OR = 1.58, p < 0.0001).
Conclusions: Prolonged CPB duration independently predicts postoperative morbidity and mortality after cardiac surgery.
Qian S, Cao B, Li P, Dong N BMC Surg. 2025; 25(1):88.
PMID: 40033317 PMC: 11874661. DOI: 10.1186/s12893-025-02817-9.
Zhang S, Wei C, Peng B, Lv L, Pei F, Xia J Front Cardiovasc Med. 2025; 12:1519251.
PMID: 39906758 PMC: 11790573. DOI: 10.3389/fcvm.2025.1519251.
Li S, Nordick K, Murrieta-Alvarez I, Kirby R, Bhattacharya R, Garcia I Biomedicines. 2025; 13(1).
PMID: 39857617 PMC: 11763025. DOI: 10.3390/biomedicines13010033.
Erol M, Beyazpinar D, Civelek I, Ozyalcin S, Mungan U Turk Gogus Kalp Damar Cerrahisi Derg. 2024; 32(4):387-393.
PMID: 39651058 PMC: 11620522. DOI: 10.5606/tgkdc.dergisi.2024.26359.
Liver Status Assessment After Coronary Artery Bypass Grafting.
Ludusanu A, Ciuntu B, Tanevski A, Fotache M, Radu V, Burlacu A Cureus. 2024; 16(10):e72210.
PMID: 39583384 PMC: 11583995. DOI: 10.7759/cureus.72210.